Live Breaking News & Updates on Mersana therapeutics inc

Stay informed with the latest breaking news from Mersana therapeutics inc on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Mersana therapeutics inc and stay connected to the pulse of your community

Brokerages Set Mersana Therapeutics, Inc. (NASDAQ:MRSN) Price Target at $6.29

Brokerages Set Mersana Therapeutics, Inc. (NASDAQ:MRSN) Price Target at $6.29
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Robertw-baird , Merck-kga , Merck-kgaa , Affinity-asset-advisors , Newtyn-management , Mersana-therapeutics-inc , Jpmorgan-chase-co , Mersana-therapeutics-company-profile , Janssen-biotech-inc , Nasdaq , Asana-biosciences

Why Teledyne Technologies Shares Are Trading Lower By 9%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session - Amesite (NASDAQ:AMST), Applied DNA Sciences (NASDAQ:APDN)

Manhattan , New-york , United-states , Canada , Vicor-corporation , Troy-limited , Hilton-worldwide-holdings-inc , B-riley-financial-inc , Mullen-automotive-inc , Concept-international-group-holdings-limited , Teledyne-technologies

Readystate Asset Management LP Makes New Investment in Mersana Therapeutics, Inc. (NASDAQ:MRSN)

Readystate Asset Management LP acquired a new position in Mersana Therapeutics, Inc. (NASDAQ:MRSN – Free Report) in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor acquired 295,038 shares of the company’s stock, valued at approximately $684,000. Readystate Asset Management LP owned 0.24% […]

Ohio , United-states , Robertw-baird , Mersana-therapeutics-inc , Merck-kgaa , Asana-biosciences , Victory-capital-management-inc , Merck-kga , Mersana-therapeutics-company-profile , Nasdaq , Janssen-biotech-inc

Mersana Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

CAMBRIDGE, Mass., April 04, 2024 (GLOBE NEWSWIRE) -- Mersana Therapeutics, Inc. (NASDAQ:MRSN), a clinical-stage biopharmaceutical company focused on discovering and developing a pipeline of antibody-drug conjugates (ADCs) targeting cancers in

Cambridge , Cambridgeshire , United-kingdom , Jason-fredette , Mersana-therapeutics-inc , Nasdaq , Nasdaq-listing-rule , Stock-incentive-plan , Region ,

Mersana Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Mersana Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Cambridge , Cambridgeshire , United-kingdom , Jason-fredette , Mersana-therapeutics-inc , Nasdaq , Nasdaq-listing-rule , Stock-incentive-plan ,

Mersana Therapeutics, Inc. (NASDAQ:MRSN) Receives Average Recommendation of "Moderate Buy" from Analysts

Shares of Mersana Therapeutics, Inc. (NASDAQ:MRSN – Get Free Report) have been given a consensus recommendation of “Moderate Buy” by the seven analysts that are presently covering the company, MarketBeat reports. Two research analysts have rated the stock with a hold recommendation and five have issued a buy recommendation on the company. The average 1 […]

Blackrock , Nova-scotia , Canada , Montreal , Quebec , Switzerland , Swiss , Anna-protopapas , Robertw-baird , Brian-deschuytner , Jpmorgan-chase-co , Securities-exchange-commission

Form 10-K Vincerx Pharma, Inc. For: Dec 31

Form 10-K Vincerx Pharma, Inc. For: Dec 31
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Brazil , China , Palo-alto , California , United-states , Delaware , India , Washington , Argentina , State-of-delaware , Germany , East-brunswick

Mersana Therapeutics (NASDAQ:MRSN) Upgraded at JPMorgan Chase & Co.

Mersana Therapeutics (NASDAQ:MRSN) Upgraded at JPMorgan Chase & Co.
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Ohio , United-states , Robertw-baird , Brian-deschuytner , Anna-protopapas , Citigroup , Merck-kgaa , Merck-kga , Janssen-biotech-inc , Jpmorgan-chase-co , Nasdaq , Victory-capital-management-inc

Truist Financial Upgrades Mersana Therapeutics (NASDAQ:MRSN) to Buy

Mersana Therapeutics (NASDAQ:MRSN – Get Free Report) was upgraded by equities researchers at Truist Financial from a “hold” rating to a “buy” rating in a note issued to investors on Thursday, Benzinga reports. The firm presently has a $9.00 price objective on the stock. Truist Financial’s price target would indicate a potential upside of 85.57% […]

Hong-kong , Robertw-baird , Anna-protopapas , Brian-deschuytner , Merck-kga , Sphera-funds-management , Y-intercept-hong-kong-ltd , Citigroup , Janssen-biotech-inc , Mersana-therapeutics-inc , Asana-biosciences , Life-insurance-co

Hormel Foods Reports Upbeat Earnings, Joins Pure Storage, Okta, Papa John's International And Other Big Stocks Moving Higher On Thursday - Hormel Foods (NYSE:HRL), Pure Storage (NYSE:PSTG), Papa John's International (NASDAQ:PZZA), Okta (NASDAQ:OKTA)

U.S. stocks were higher, with the Nasdaq Composite gaining around 50 points on Thursday.

Perini-corporation , Mersana-therapeutics-inc , Sprinklr-inc , Montrose-environmental-group-inc , Nasdaq , Taskus-inc , Vertex-inc , Avidity-biosciences-inc , Papa-john-international-inc , Hayward-holdings-inc , Sunopta-inc